Whales with a lot of money to spend have taken a noticeably bearish stance on Soleno Therapeutics.
Looking at options history for Soleno Therapeutics SLNO we detected 10 trades.
If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened trades with bullish expectations and 50% with bearish.
From the overall spotted trades, 6 are puts, for a total amount of $3,027,189 and 4, calls, for a total amount of $953,750.
Projected Price Targets
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $40.0 to $60.0 for Soleno Therapeutics during the past quarter.
Analyzing Volume & Open Interest
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Soleno Therapeutics's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Soleno Therapeutics's whale activity within a strike price range from $40.0 to $60.0 in the last 30 days.
Soleno Therapeutics Option Volume And Open Interest Over Last 30 Days
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SLNO | PUT | TRADE | BULLISH | 01/16/26 | $15.0 | $10.6 | $11.5 | $55.00 | $2.0M | 0 | 1.7K |
| SLNO | CALL | TRADE | BEARISH | 01/17/25 | $4.9 | $3.9 | $4.1 | $60.00 | $820.0K | 140 | 2.0K |
| SLNO | PUT | TRADE | NEUTRAL | 01/17/25 | $5.2 | $3.0 | $4.0 | $40.00 | $800.0K | 26 | 5.1K |
| SLNO | CALL | SWEEP | BULLISH | 01/17/25 | $9.0 | $7.9 | $8.5 | $55.00 | $83.5K | 380 | 102 |
| SLNO | PUT | SWEEP | BEARISH | 01/17/25 | $4.9 | $3.3 | $4.4 | $45.00 | $73.3K | 21 | 167 |
About Soleno Therapeutics
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.
In light of the recent options history for Soleno Therapeutics, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Soleno Therapeutics's Current Market Status
- With a volume of 2,551,056, the price of SLNO is up 8.21% at $51.54.
- RSI indicators hint that the underlying stock may be approaching overbought.
- Next earnings are expected to be released in 28 days.
Professional Analyst Ratings for Soleno Therapeutics
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $70.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $67. * Maintaining their stance, an analyst from Stifel continues to hold a Buy rating for Soleno Therapeutics, targeting a price of $74.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Soleno Therapeutics with Benzinga Pro for real-time alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
